Press Release

ASKA Pharmaceutical Launches “Training Videos on Women's Health”
TOKYO, September 21, 2023 - ASKA Pharmaceutical Co., Ltd. (Head Office: Minato-ku, Tokyo;
President: Sohta Yamaguchi; hereinafter “ASKA”), a subsidiary of ASKA Pharmaceutical Holdings
Co., Ltd., established the Femtech Business Promotion Unit in April of this year to make a broad
contribution to women's healthcare. ASKA is pleased to announce that it will start selling “trainingvideos on women's health” as the first step of the Unit.
Since its establishment in 1920, ASKA has been manufacturing and selling ethicalpharmaceuticals, focusing on obstetrics and gynecology as a company that supports women'shealth. In 2020, on its 100th anniversary, ASKA launched the “Health Lab Mint⁺ for Women'shealth” as initiatives for women in general. This time, to further develop the activities of Mint⁺,
ASKA will launch the “Mint⁺ Femknowledge,” training videos on women's health based on theconcept of “what workers should know about sex” for all people working in companies,organizations, and others.
Videos on Women's Health
Background:As more working women play an increasingly active role in Japan, thesocioeconomic loss caused by menstrual and menopausal symptoms thatprevent them from performing at their best has become a significant issue.
As a leading company in the field of obstetrics and gynecology, ASKA
believes it is an essential mission to contribute to the improvement of healthliteracy by providing accurate and necessary information on women's health.

Targets:

All people who work for companies, organizations, etc.

Benefits:

Viewing the videos will bring benefits to you as below:‐

Improve awareness of women's health among men and women, which
will help create a work environment where everyone can respect eachother and play an active role.

‐

Enhance individual productivity and contribute to sustainable growth forcompanies and organizations.

‐

Help create solutions that can help improve health management
outcomes.

Features:‐

Reliable content supervised by a medical specialist (Dr. Yasunori
Yoshimura, Professor Emeritus of Keio University).

‐

Explains the structure of female bodies and various issues in a way evenmen can easily understand.

‐

Each video plays for 5 to 6 minutes (16 videos in total, to be added indue course) and can be easily accessed from smartphones and othermobile devices.
‐

Participants can deepen their understanding by taking a post-viewing‐

Survey results before and after viewing the video help you confirm theconfirmation quiz.
current status and issues.
Release date:

October 3, 2023 (Tuesday)*Please visit the Mint⁺ Femknowledge (scheduled to be released on October 3, 2023) to learn
more about the training videos and to inquire about them.
About Mint⁺ Femknowledge
URL:

https://www.aska-pharma.co.jp/femknowledge/* Japanese version only
“Femknowledge” is a coined word that combines“Femtech” and “Knowledge” in the hope that it willsolve women's specific issues by improving theirhealth literacy. Under the concept of “Withoutknowing, there is no mutual understanding,” itprovides a place to offer correct information about
women's health, as well as concerns about
sexuality and solutions to visitors.
Femknowledge is a registered trademark of ASKA.

Contents:(1) Training videos on women's health for companies and organizations(2) Introduction of Femtech-related information and Femtech-relatedproducts and services:
Articles and advertisements introducing products and services ofFemtech-related companies will be posted on the website.
(3) Educational materials for educators

Release date:

October 3, 2023 (Tuesday)About ASKA Pharmaceutical Co., Ltd.
Since its foundation in 1920, ASKA Pharmaceutical, as a specialty pharma company with a focus
on internal medicine, obstetrics and gynecology, and urology, has been providing products related
to healthcare in these therapeutic areas and has been working to enhance its product lineup.
For more information, please visit: https://www.aska-pharma.co.jp/english

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd.
Corporate Planning Department
Tel: +81-3-5484-8366
Email: kouhou@aska-pharma.co.jp